Show simple item record

dc.contributor.authorYildiz, E
dc.contributor.authorGokce, G
dc.contributor.authorKilicarslan, H
dc.contributor.authorAyan, S
dc.contributor.authorGoze, OF
dc.contributor.authorGultekin, EY
dc.date.accessioned2019-07-27T12:10:23Z
dc.date.accessioned2019-07-28T10:22:59Z
dc.date.available2019-07-27T12:10:23Z
dc.date.available2019-07-28T10:22:59Z
dc.date.issued2004
dc.identifier.issn1464-4096
dc.identifier.urihttps://dx.doi.org/10.1111/j.1464-410X.2004.04786.x
dc.identifier.urihttps://hdl.handle.net/20.500.12418/11267
dc.descriptionWOS: 000221254400037en_US
dc.descriptionPubMed ID: 15142169en_US
dc.description.abstractTo determine if use of cell proliferation, cell adhesion, level of angiogenesis-related factors and presence of microscopic vascular invasion (MVI) could better predict the biological behaviour of renal cell carcinoma (RCC), which has a widely variable clinical outcome despite the use of conventional prognostic factors (staging and grading). The expression of Ki-67, CD44H and vascular endothelial growth factor (VEGF) were assessed immunohistochemically in formalin-fixed, paraffin-embedded tissues from 48 RCCs, using a Ki-67 labelling index (LI), CD44 LI and level of VEGF expression, respectively. In addition all the pathological slides were reviewed retrospectively for the presence and absence of MVI. The prognostic value of all the variables assessed was then evaluated, and correlated with the usual prognostic variables and cancer-specific survival. Univariate analysis of cancer-specific survival showed that tumour stage (P < 0.001), tumour size (P = 0.005), metastasis, MVI, Ki-67 LI, CD44H LI and VEGF expression (all P < 0.001) were predictors of tumour-related death. There was a statistical correlation between CD44H LI and each of Ki-67 LI (r = 0.61), expression level of VEGF (r = 0.72) and presence of MVI (r = 0.71). Independent predictors of cancer-specific survival in a multivariate analysis were: in all patients with RCC, the MVI (P = 0.003) and VEGF expression (P = 0.01); in those with no metastases, MVI (P = 0.01); in patients with no MVI, VEGF (P = 0.04); and in patients with MVI, Ki-67 LI (P = 0.003). No independent predictor was identified in patient with metastases. This study suggests that cell proliferation, cell adhesion, the level of VEGF expression and the presence of MVI represent a complex tumour-host interaction that may favour the progression of RCC. Cell proliferation, CD44H and VEGF expression appear to be powerful markers for identifying patients with an adverse prognosis.en_US
dc.language.isoengen_US
dc.publisherBLACKWELL PUBLISHING LTDen_US
dc.relation.isversionof10.1111/j.1464-410X.2004.04786.xen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectrenal cell carcinomaen_US
dc.subjectKi-67en_US
dc.subjectCD44en_US
dc.subjectVEGFen_US
dc.subjectmicrovessel invasionen_US
dc.subjectprognosisen_US
dc.titlePrognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinomaen_US
dc.typearticleen_US
dc.relation.journalBJU INTERNATIONALen_US
dc.contributor.departmentCumhuriyet Univ, Fac Med, Dept Pathol, TR-58140 Sivas, Turkey -- Cumhuriyet Univ, Fac Med, Dept Urol, TR-58140 Sivas, Turkeyen_US
dc.identifier.volume93en_US
dc.identifier.issue7en_US
dc.identifier.endpage1093en_US
dc.identifier.startpage1087en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record